1. ) Atmosic Technologies Announces New Energy Harvesting Technique that Enables “Forever” Battery Life
Built on Atmosic’s M3 Series chipset, the company’s energy harvesting technology captures photovoltaic power from ambient light sources, which are sufficient to power Atmosic-connected devices and enable “forever” battery life. The M3 series chipset is mainly utilized for ultra-low energy Bluetooth linked devices. Atmosic’s new technology allows for 10-100x lower power requirements than other options on the market. The M3 Series silicon is sampling with customers now and will be in mass production at the end of Q2 2019.
Researchers have observed a new storm forming on Neptune. Astronomers analyzed Hubble data from the past four years and observed the new storm in the form of a large dark spot that appeared in late 2018. The discovery highlights that high-altitude clouds form years ahead of the visible storm, which indicates the storm is already forming there, swirling beneath the clouds and haze. It is expected that this http://www.astronomy.com/news/2019/03/hubble-catches-neptune-forming-new-massive-stormswill teach astronomers more about how storms form and evolve on gas giants.
The pill, known as 11-beta-MNTDC, has passed the first round of rigorous human safety tests, with research from the Los Angeles Biomedical Research Institute (LA BioMed) and the University of Washington showing promising results. Unlike other male contraceptive pills, 11-beta-MNTDC reduces the hormones required for sperm production but does not impact sexual performance. 11-beta-MNTDC still faces a long road before it is approved and widely available. Researchers intend to submit the drug to the FDA which will oversee Stage 2 and Stage 3 trials.
In a paper published on BioRxiv, researchers from George Church’s Harvard lab announced that they had successfully introduced more than 13,000 CRISPR edits into a single cell. This shattered the old record of approximately 500 edits. Even more importantly, the cell was still viable after the edits were made. Prior attempts at widespread genomic editing had failed to produce viable cells post-CRISPR. The lab’s ultimate goal is to create supplies of organs and tissues that have been edited to be immune to viruses.
Scientists studying Alzheimer’s disease found that humans are able to produce new brain cells into their 90s and possibly beyond. In a study published in the journal “Nature Medicine”, researchers found that adult brains showed evidence of neurogenesis. Researchers also found that the brains of Alzheimer’s patients showed fewer signs of newly created brain cells. The study authors stated that it may be possible to diagnose Alzheimer’s at a very early stage with future brain scanning techniques.